Glossary
Plain-English meanings of the 34 regulatory and clinical trial terms used on Psychedelic Monitor. Each entry says what a term means, not whether a treatment works. In summaries, the first use of a term has a dotted underline.
A
- adverse event
- Any unwanted medical occurrence in a trial participant, whether or not it was caused by the treatment. Also written: adverse events.
- ANZCTR
- The Australian New Zealand Clinical Trials Registry, a public register of clinical trials.
- ARTG
- The Australian Register of Therapeutic Goods, the list of therapeutic goods that can lawfully be supplied in Australia. Also written: Australian Register of Therapeutic Goods.
B
- breakthrough therapy designation
- An FDA status that speeds up the development and review of a drug for a serious condition; it is not an approval. Also written: Breakthrough Therapy designation.
C
- ClinicalTrials.gov
- A public register of clinical trials run by the US National Library of Medicine; its trial numbers start with NCT.
D
- double-blind
- A study in which neither participants nor the researchers assessing them are told who received which treatment. Also written: double blind, double-blinded.
E
- EMA
- The European Medicines Agency, which evaluates medicines for the European Union. Also written: European Medicines Agency.
F
- FDA
- The Food and Drug Administration, the United States regulator of medicines, medical devices and food. Also written: Food and Drug Administration.
H
- HREC
- A Human Research Ethics Committee, the Australian body that reviews research involving people before it can start. Also written: Human Research Ethics Committee.
I
- IND
- An investigational new drug application, which must be in effect with the FDA before a new drug is tested in people in the United States. Also written: investigational new drug application.
M
- MBS item
- A health service listed on the Medicare Benefits Schedule, for which Medicare pays a rebate. Also written: MBS items, Medicare Benefits Schedule.
- meta-analysis
- A statistical method that combines the results of several studies into one estimate. Also written: meta-analyses, meta analysis.
N
- NDA
- A new drug application, the formal request asking the FDA to approve a new medicine for sale in the United States. Also written: new drug application.
O
- open-label
- A study in which participants and researchers both know which treatment is being given. Also written: open label.
P
- PBS
- The Pharmaceutical Benefits Scheme, the Australian Government program that subsidises the cost of listed medicines. Also written: Pharmaceutical Benefits Scheme.
- peer review
- Checking of a research paper by independent experts in the field before a journal publishes it. Also written: peer-reviewed, peer reviewed.
- Phase 1
- The first studies of a drug in people, usually in small numbers, looking mainly at safety and dose. Also written: Phase I, Phase 1a, Phase 1b.
- Phase 2
- Mid-stage trials in people with the condition, looking at dose, safety and early signs of effect. Also written: Phase II, Phase 2a, Phase 2b.
- Phase 3
- Larger trials meant to confirm a drug's effects and safety, usually needed before a regulator will consider approving it. Also written: Phase III.
- placebo-controlled
- A study that compares the treatment with an inactive or low-dose look-alike, called a placebo.
- Poisons Standard
- The Australian legal instrument that sorts medicines and chemicals into schedules, which set how each can be supplied.
- preprint
- A research paper shared publicly before it has been peer reviewed. Also written: preprints.
- primary endpoint
- The main result a trial is designed to measure, chosen before the trial starts. Also written: primary endpoints, primary outcome.
- PTSD
- Post-traumatic stress disorder, a mental health condition that can follow exposure to a traumatic event. Also written: post-traumatic stress disorder, posttraumatic stress disorder.
R
- RCT
- A randomised controlled trial, in which participants are assigned by chance to the treatment being tested or to a comparison. Also written: randomised controlled trial, randomized controlled trial, randomised controlled trials, randomized controlled trials.
- rescheduling
- Moving a substance to a different schedule in drug-control or poisons law, which changes how it can be supplied and used. Also written: rescheduled, reschedule, reschedules.
S
- Schedule 8
- The Poisons Standard category for controlled drugs: medicines that can be prescribed, under tighter controls than ordinary prescription medicines.
- Schedule 9
- The Poisons Standard category for prohibited substances, which can be used only in approved research, teaching or analysis.
- Special Access Scheme
- A TGA pathway that lets a health practitioner seek access to an unapproved therapeutic good for a single patient.
- systematic review
- A review that uses a stated, repeatable method to find and assess all the studies on a question. Also written: systematic reviews.
T
- TGA
- The Therapeutic Goods Administration, Australia's national regulator of medicines and medical devices. Also written: Therapeutic Goods Administration.
- topline results
- A first summary of a trial's main outcomes, usually released by the sponsor before full data are published or peer reviewed. Also written: top-line results, topline data, top-line data.
- treatment-resistant depression
- Depression that has not improved enough after adequate courses of at least two antidepressant treatments. Also written: TRD.
These are general definitions, not medical or legal advice. About this site